Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

3D bioprinting of functional meniscus constructs with anisotropic properties using meniscus-derived bioink for knee meniscus regeneration.

Biofabrication·2026
Same author

Pharmacological treatments and clinical events in newly diagnosed heart failure patients stratified by ejection fraction in Japan.

Scientific reports·2026
Same author

Visible-Light-Curable Catechol-Reinforced Gelatin Bioglue for Rapid Hemostasis and Engineered Tissue Assembly.

Biomaterials research·2026
Same author

Real-world patient characteristics and clinical outcomes in patients with myelofibrosis in Japan.

PloS one·2026
Same author

High-yield cell-derived extracellular matrix bioink via macromolecular crowding for versatile 3D bioprinting.

Materials today. Bio·2026
Same author

Airway mucosa-derived extracellular matrix bioink for 3D bioprinting of functional airway tissue.

Biofabrication·2026

Related Experiment Video

Updated: Feb 24, 2026

3D Cell-Printed Hypoxic Cancer-on-a-Chip for Recapitulating Pathologic Progression of Solid Cancer
10:51

3D Cell-Printed Hypoxic Cancer-on-a-Chip for Recapitulating Pathologic Progression of Solid Cancer

Published on: January 5, 2021

5.2K

3D Cell Printed Tissue Analogues: A New Platform for Theranostics.

Yeong-Jin Choi1, Hee-Gyeong Yi2, Seok-Won Kim2

  • 1Division of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology (POSTECH), 77 Cheongam-ro, Nam-gu, Pohang, Gyeongbuk 790-781, Republic of Korea.

Theranostics
|August 26, 2017
PubMed
Summary

Three-dimensional (3D) cell printing enhances stem cell therapy by creating tissue constructs with improved viability and function. This review explores 3D bioprinting for stem cell theranostics, addressing tracking and monitoring challenges.

Keywords:
Three-dimensional (3D) cell printingstem cell theranostics

More Related Videos

Ceramic Omnidirectional Bioprinting in Cell-Laden Suspensions for the Generation of Bone Analogs
10:19

Ceramic Omnidirectional Bioprinting in Cell-Laden Suspensions for the Generation of Bone Analogs

Published on: August 8, 2022

2.5K
Author Spotlight: Advancing Tendon Tissue Engineering with 3D Organoid Models
03:35

Author Spotlight: Advancing Tendon Tissue Engineering with 3D Organoid Models

Published on: June 21, 2024

2.4K

Related Experiment Videos

Last Updated: Feb 24, 2026

3D Cell-Printed Hypoxic Cancer-on-a-Chip for Recapitulating Pathologic Progression of Solid Cancer
10:51

3D Cell-Printed Hypoxic Cancer-on-a-Chip for Recapitulating Pathologic Progression of Solid Cancer

Published on: January 5, 2021

5.2K
Ceramic Omnidirectional Bioprinting in Cell-Laden Suspensions for the Generation of Bone Analogs
10:19

Ceramic Omnidirectional Bioprinting in Cell-Laden Suspensions for the Generation of Bone Analogs

Published on: August 8, 2022

2.5K
Author Spotlight: Advancing Tendon Tissue Engineering with 3D Organoid Models
03:35

Author Spotlight: Advancing Tendon Tissue Engineering with 3D Organoid Models

Published on: June 21, 2024

2.4K

Area of Science:

  • Regenerative Medicine
  • Biotechnology
  • Medical Imaging

Background:

  • Stem cell therapy faces limitations like low retention, survival, and engraftment.
  • Stem cell theranostics aims to monitor transplanted cells noninvasively.
  • Current stem cell therapy efficacy is hindered by poor cell integration and survival post-transplantation.

Purpose of the Study:

  • To review advancements in 3D cell printing for stem cell theranostics.
  • To highlight how 3D bioprinting can overcome stem cell therapy limitations.
  • To discuss the noninvasive monitoring and tracking of 3D cell-printed tissues.

Main Methods:

  • Literature review of 3D cell printing technologies and applications in stem cell theranostics.
  • Analysis of imaging agents and modalities for cell tracking.
  • Exploration of tissue engineering strategies using 3D bioprinting.

Main Results:

  • 3D cell printing creates tissue constructs mimicking native architecture and microenvironment.
  • 3D bioprinted constructs show enhanced cell viability, regenerative capacity, and functionality.
  • Noninvasive in vivo and in vitro tracking of 3D cell-printed tissues remains an area needing further research.

Conclusions:

  • 3D cell printing offers a promising approach to enhance stem cell therapy efficacy.
  • Addressing real-time monitoring and tracking of 3D bioprinted constructs is crucial for clinical translation.
  • Future research should focus on integrating advanced imaging techniques with 3D bioprinting for improved stem cell theranostics.